doi: 10.1111/j.1532-5415.1968.tb02682.x.
Hyperkalemic changes during spironolactone therapy for cirrhosis and ascites, with special reference to hyperkalemic intermittent paralysis
- PMID: 5666934
- DOI: 10.1111/j.1532-5415.1968.tb02682.x
Item in Clipboard
Hyperkalemic changes during spironolactone therapy for cirrhosis and ascites, with special reference to hyperkalemic intermittent paralysis
J Am Geriatr Soc.
1968 Aug.
No abstract available
Similar articles
-
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.Am Heart J. 1968 Sep;76(3):393-8. doi: 10.1016/0002-8703(68)90236-6. Am Heart J. 1968. PMID: 4951338 No abstract available.
-
Iatrogenic hyperkalemic paralysis with electrocardiographic changes.South Med J. 1974 Mar;67(3):342-5. doi: 10.1097/00007611-197403000-00024. South Med J. 1974. PMID: 4814187 No abstract available.
-
[Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].Schweiz Med Wochenschr. 1971 Mar 20;101(11):398-401. Schweiz Med Wochenschr. 1971. PMID: 5558553 French. No abstract available.
-
Diuretic drug therapy of edema.Med Clin North Am. 1971 Mar;55(2):359-72. doi: 10.1016/s0025-7125(16)32525-1. Med Clin North Am. 1971. PMID: 4926056 Review. No abstract available.
-
[New "diuretics" in therapy of ascites].Z Gastroenterol Verh. 1991 Mar;26:144-8. Z Gastroenterol Verh. 1991. PMID: 1714129 Review. German. No abstract available.
Cited by
-
Biochemical Risk Factors Associated With Hyperkalemia in Cirrhotic Patients.Cureus. 2021 Sep 28;13(9):e18356. doi: 10.7759/cureus.18356. eCollection 2021 Sep. Cureus. 2021. PMID: 34725608 Free PMC article.
-
Reversible renal resistance to aldosterone associated with interstitial nephritis.West J Med. 1987 Jun;146(6):742-5. West J Med. 1987. PMID: 3617719 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
